IRIS
DAMIANI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.951
AS - Asia 6.766
EU - Europa 5.211
SA - Sud America 1.349
AF - Africa 143
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 5
Totale 29.441
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.727
SG - Singapore 3.053
UA - Ucraina 1.541
CN - Cina 1.524
BR - Brasile 1.061
DE - Germania 802
HK - Hong Kong 732
FI - Finlandia 621
IT - Italia 506
VN - Vietnam 451
RU - Federazione Russa 387
FR - Francia 375
SE - Svezia 336
IE - Irlanda 257
TR - Turchia 164
GB - Regno Unito 162
IN - India 161
KR - Corea 158
CA - Canada 148
BD - Bangladesh 88
AR - Argentina 86
IQ - Iraq 76
CO - Colombia 57
MX - Messico 47
PK - Pakistan 43
EC - Ecuador 41
ZA - Sudafrica 38
ID - Indonesia 36
JP - Giappone 36
PL - Polonia 34
UZ - Uzbekistan 31
IR - Iran 29
SA - Arabia Saudita 28
NL - Olanda 27
CZ - Repubblica Ceca 26
MA - Marocco 26
CL - Cile 25
VE - Venezuela 24
ES - Italia 21
PY - Paraguay 20
AT - Austria 18
BE - Belgio 18
JO - Giordania 17
PH - Filippine 17
EU - Europa 13
MY - Malesia 13
AE - Emirati Arabi Uniti 12
EG - Egitto 12
KZ - Kazakistan 12
PE - Perù 12
UY - Uruguay 12
TG - Togo 11
AZ - Azerbaigian 10
IL - Israele 10
KE - Kenya 10
RO - Romania 10
TN - Tunisia 10
BO - Bolivia 9
OM - Oman 9
BG - Bulgaria 8
DZ - Algeria 8
RS - Serbia 8
AL - Albania 7
BH - Bahrain 7
JM - Giamaica 7
KG - Kirghizistan 7
LT - Lituania 7
LB - Libano 6
SY - Repubblica araba siriana 6
CH - Svizzera 5
GE - Georgia 5
HN - Honduras 5
HU - Ungheria 5
AU - Australia 4
ET - Etiopia 4
LV - Lettonia 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BY - Bielorussia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
KW - Kuwait 3
PS - Palestinian Territory 3
RW - Ruanda 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
BJ - Benin 2
CR - Costa Rica 2
GA - Gabon 2
GL - Groenlandia 2
HR - Croazia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
ML - Mali 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
Totale 29.406
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.113
Ann Arbor 1.688
Singapore 1.253
Fairfield 1.222
Houston 1.190
Jacksonville 1.105
Ashburn 969
Beijing 828
Chandler 762
Hong Kong 724
Dearborn 590
San Jose 515
Wilmington 505
Seattle 448
Cambridge 374
Boardman 301
Dublin 255
Princeton 252
Lauterbourg 238
Los Angeles 219
Dallas 172
Ho Chi Minh City 153
Seoul 146
Hefei 143
Buffalo 130
Udine 112
Izmir 111
Munich 110
San Diego 102
Helsinki 95
São Paulo 90
Hanoi 88
New York 86
Ottawa 77
Trieste 65
The Dalles 63
Ogden 62
Norwalk 56
Santa Clara 56
Orem 51
Turku 46
Redondo Beach 45
Des Moines 42
Rio de Janeiro 39
Council Bluffs 38
Nanjing 35
Tokyo 35
Montreal 33
Mumbai 33
Baghdad 32
Warsaw 30
Frankfurt am Main 29
Regensburg 29
Kunming 28
Tashkent 28
Dong Ket 25
Phoenix 25
Atlanta 24
Porto Alegre 24
Belo Horizonte 23
Chennai 23
Toronto 23
Guangzhou 22
London 22
Pittsburgh 21
Stockholm 21
Brasília 19
Da Nang 19
Poplar 19
Simi Valley 19
Augusta 18
Brussels 18
Denver 18
Johannesburg 18
Boston 17
Jinan 17
Mexico City 17
Nuremberg 17
Rome 17
Amman 16
Bogotá 16
Washington 16
Andover 15
Brooklyn 15
Curitiba 15
Milan 15
Quito 15
Chicago 14
Istanbul 14
Lahore 14
Leawood 14
Nanchang 14
San Francisco 14
Asunción 13
Campinas 13
Guarulhos 13
Haiphong 13
Manchester 13
Caxias do Sul 12
Dhaka 12
Totale 18.823
Salva come PNG Salva come JPEG
Nome #
Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy 277
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 222
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology 217
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 205
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non MDR cells to different anthracycline derivatives 200
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 197
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 196
“Fibre nervose peptidergiche intraepidermiche: uno studio immunoistochimico”. 191
B-cell immune reconstitution after allogenic stem cell transplantation and its role in the development of chronic graft-versus-host disease 178
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years 177
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. 175
Histone post-translational modifications associated to BAALC expression in leukemic cells. 173
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells 173
ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia 173
ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission 172
P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia. 170
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome 170
Multipotent Mesenchymal Stem Cells Can Be Isolated and Grown from Many Tissues (Bone Marrow, Liver and Heart) 170
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 169
A mutational status of IGVH genes consisten with antigen-driven selection has prognostic impact istead of percento f mutations in B-cell chronic lymphocytic leukemia 163
BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine 163
Clinical feature and outcome in seven patients wuth hyaline or mixed variant of Castleman’s disease. A single centre experience 160
A study of the material in the ATLAS inner detector using secondary hadronic interactions 160
5-AZACITIDINE FIVE DAYS/MONTHLY SCHEDULE IN SYMPTOMATIC LOW-RISK (IPSS: 0-1) MYELODISPLASTIC (MDS) PATIENTS. CLINICAL AND BIOLOGICAL EFFECTS Authors 159
Autologus stem cell transplantation as postremission therapy for acute myeloid leukemia. Risk factors at diagnosis can predict the outcome. 158
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia 157
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML 157
Erratum: Functional regulation of the Apurinic/apyrimidinic endonuclease APE1 by Nucleophosmin (NPM1): Impact on tumor biology 155
“Overexpression of multidrug resistance-associated P-170 glycoprotein in acute non lymphocytic leukemia”. 154
Autologous stem cell transplantation in chronic carriers of hepatitis B virus and hepatitis C virus affected by onco-hematologic diseases. 151
Suggestive evidence for a Microanatomical Relationship betweeb Mast Cells and Nerve Fibres Containing Substance P, Calcitonin Gene Related Peptide, Vasoactive Intestinal Polypeptide, and Somatostatin in the rat Mesentery. 150
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia 150
Unexpected phenotype of a typical NPM1 mutant 149
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. 149
Longitudinal follow-up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogeneic bone marrow transplant 147
Granulocyte-macrophage colony -stimulating factor in acute nonlymphocytic leukemia before and after chemo therapy”. 147
Acute promyelocytic leucemia: low expression of multidrug resistance phenotype at onset suggest a favourable effect of gentuzumab ozogamicyn (CMA-676 145
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 145
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 145
Visualization of PGP 9.5 immunoreactive nerve terminals in the mouse snout epidermis. 145
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 145
A simple Prognostic Scoring System for newly diagnosed acute leukaemia patients with normal karyotype: a retrospective analysis on 173 cases. 144
Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera. 144
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 years treated with induction regimens including fludarabine: retrospective analysis of 224 cases 143
The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia. 143
ABCB1 (PGP) and ABCG (BCRP) proteins are independent prognostic factors for complete remissione and relapse risk, respectively in normal karyotype adult de novo acute myeloid leukemia. 142
Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement 141
Antibody binding capacity for evaluation of MDR-related proteins in acute promyelocytic leukemia: Onset versus relapse expression 141
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. 140
“Long Term Follow-up of the Italian Trial of Interferon-a Versus Conventional Chemotherapy in Chronic Myeloid Leukemia”. 139
“D-Verapamil downmodulates P-170 associated resistance to doxorubicin, daunorubicin and idarubicin”. 138
KERATOCONJUNCTIVITIS TREATMENT WITH AUTOLOGOUS SERUM EYE IN PATIENTS WITH SEVERE CHRONIC GVHD 138
KIR POLYMORPHISM IN REDUCED INTENSITY HLA-ID SIBLING STEM CELL TRANSPLANTATION: IMPACT ON CLINICAL OUTCOME 138
Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy. 138
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias 138
CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis”. 137
FEASIBILITY OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH CD34 SELECTED STEM CELLS: OUTCOME AND IMMUNOLOGICAL COMPLICATIONS 136
“CD34+ selected versus un-manipulated autologous stem cell transplantation in multiple myeoloma: impact on dendritic and immune recovery and on complications due to infections”. 136
Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia. 136
Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy. 135
“Case report: mdr-1 gene amplification in acute lymphoblastic leukemia prior to antileukemic treatment”. 135
Acute promyelocyttic leucemia: low expression of multidrug resistance phenotype at onset suggests a favorable effect of Gemtuzumab Ozogamycin (CMA 676) 134
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 134
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype 134
Intensified full-dose induction therapy (HD-MACHOP+radiotherapy) follwed dy consolidation with BAVC regimen and autologous stem cell transplantation as fron-line therapeutic approach for high risk aggressive non Hodgkin lymphoma 133
Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow) 133
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients 133
“Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas”. 132
Dendritic cell recovery after autologous stem cell transplantation 132
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients 132
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance 132
Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia 131
Prognostic factors anad expression of multidrug-resistance related proteins in 36 patients with acute promyelocytic leukemia. 130
“Espressione dell’antigene CD34 nei tessuti normali e patologici e possibili applicazioni cliniche delle cellule CD34”. 130
“The use of G-CSF during first line chemotherapy adversely affects the yield of PBSC mobilization in non-Hodgkins’ Lymphoma patients” 130
Castleman's disease: an unusual cause of mediastinal mass and anemia. 130
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults. 128
A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of aurtologoaus stem cell transplantation in first remission on autcome 128
P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias 127
Flow cytometry evaluation of plasma cells contaminating leukapheresis pre- and post- CD34-positive selection- 126
Peripheral blood stem cell mobilization in multiple myeloma: advantage of 7 vs. 4 g/m2 cyclophosfamide on stem cell quality and plasma cell mobilization. 126
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. 126
Clinical characteristics, prognostic factors and multidrug-resistance related protein expression in 36 adult patients with acute promyelocytic leukemia 125
Allogeneic stem cell transplantation as salvage therapy for patients with lymphoma. 124
The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leucemia 124
Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells. 123
Epstein-Barr virus (EBV) reactivation in a patient treated with ATG for severe aplastic anemia 123
Sequential study of cytokine and lymphocyte patterns in patients with chronic agraft versus host disease after reduced intensity conditioning allogenic stem cell transplantation 123
Serotoninergic fibres form dense synaptic contacts with Purkinje cells in the mouse cerebellar cortex--an immunohistochemical study 123
Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemia. 122
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) in de novo adult acute lymphoblastica leukemia 122
Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery 122
High dose therapy with stem cell rescue in elderly atients with aggressive poor risk lymphomas: a review of 14 cases. 121
Effect of fludarabine and arabinosylcytosine on multidrug resistant cells. 121
A SIMPLE PROGNOSTIC SCORING SYSTEM FOR NEWLY DIAGNOSED ACUTE LEUKAEMIA PATIENTS WITH NORMAL KARYOTYPE: A RETROSPECTIVE ANALYSIS ON 420 CASES 121
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse 121
“Multidrug resistance (MDR1) in acute myelogenous leukemia: is it time to test?” 120
“Treatment of Ph+ chronic myeloid leukemia by gamma interferon”. 120
Proliferation and maturation effects of in vivo granulo-monocyte colony stimulating factor in acute non-lymphocytic leucemia”. 119
DENDRITIC CELL RECOVERY AFTER AUTOLOGOUS AND ALLOGENEIC TRANSPLANTATION 118
Totale 14.674
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.137
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021571 0 0 0 0 0 0 0 0 0 68 414 89
2021/20221.898 53 276 69 167 64 47 78 103 19 311 396 315
2022/20231.861 273 97 16 226 188 519 6 149 254 31 57 45
2023/2024600 98 58 35 27 71 84 10 33 86 44 13 41
2024/20254.435 87 346 209 117 140 187 262 285 476 247 867 1.212
2025/20267.291 704 779 644 733 1.087 695 1.119 280 614 636 0 0
Totale 29.802